WallStSmart

Nomura Holdings Inc ADR (NMR)vsCharles Schwab Corp (SCHW)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 8639% more annual revenue ($2.17T vs $24.80B). SCHW leads profitability with a 38.0% profit margin vs 16.7%. NMR appears more attractively valued with a PEG of 0.82. SCHW earns a higher WallStSmart Score of 75/100 (B+).

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.0Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

SCHW

Strong Buy

75

out of 100

Grade: B+

Growth: 8.0Profit: 8.0Value: 5.7Quality: 6.5
Piotroski: 6/9Altman Z: -0.14

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NMR4 strengths · Avg: 8.5/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

P/E RatioValuation
12.1x8/10

Attractively priced relative to earnings

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

SCHW6 strengths · Avg: 8.8/10
Profit MarginProfitability
38.0%10/10

Keeps 38 of every $100 in revenue as profit

Operating MarginProfitability
49.3%10/10

Strong operational efficiency at 49.3%

Market CapQuality
$158.17B9/10

Large-cap with strong market position

Revenue GrowthGrowth
15.8%8/10

15.8% revenue growth

EPS GrowthGrowth
38.6%8/10

Earnings expanding 38.6% YoY

Free Cash FlowQuality
$7.20B8/10

Generating 7.2B in free cash flow

Areas to Watch

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

SCHW1 concerns · Avg: 2.0/10
Altman Z-ScoreHealth
-0.142/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : NMR

The strongest argument for NMR centers on Price/Book, PEG Ratio, P/E Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bull Case : SCHW

The strongest argument for SCHW centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 38.0% and operating margin at 49.3%. Revenue growth of 15.8% demonstrates continued momentum.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Bear Case : SCHW

The primary concerns for SCHW are Altman Z-Score.

Key Dynamics to Monitor

SCHW carries more volatility with a beta of 0.77 — expect wider price swings.

NMR is growing revenue faster at 27.5% — sustainability is the question.

SCHW generates stronger free cash flow (7.2B), providing more financial flexibility.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SCHW scores higher overall (75/100 vs 70/100), backed by strong 38.0% margins and 15.8% revenue growth. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Charles Schwab Corp

FINANCIAL SERVICES · CAPITAL MARKETS · USA

The Charles Schwab Corporation is an American multinational financial services company. It offers banking, commercial banking, an electronic trading platform, and wealth management advisory services to both retail and institutional clients.

Visit Website →

Want to dig deeper into these stocks?